Stock screener

SRPT

Conviction 57HealthcareScan · Fri, Sep 4, 2026
SRPT$22.51-2.09%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 3.14M
Jun 8Jun 25Jul 15Jul 31Aug 19Sep 4
Sarepta Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.sarepta.com ↗
Price22.51
Change-2.09%
Gap-2.65%
Rel volume0.82×
Avg volume2.86M
Avg $ vol57.76M
SMA 2019.71
SMA 5018.21
SMA 20019.18
Price vs 50+23.61%
Price vs 200+17.36%
MA stackmixed
50/200 cross—
Supertrendup · 18.88
RSI (14)68
MACD hist0.37
MACD cross—
Stoch %K / %D81 / 88
ADX (14)34
+DI / −DI37 / 12
RSI divergence—
MACD divergenceBearish
ATR %+5.46%
ADR %5.69%
52w high24.45
52w low14.86
From 52w high-7.93%
Above 52w low+51.48%
New 52w highNo
SqueezeOff
Bollinger width36.35%
%B0.89
Donchian pos84.67%
Donchian high23.62
Donchian low16.38
AVWAP (52w high)19.53
vs AVWAP high+15.25%
AVWAP (52w low)17.84
vs AVWAP low+26.14%
OBV trendUp
Chaikin MF (20)0.33
Today vs 20d0.82×
Avg vol (14d)3.1M
Avg vol (20d)2.86M
Avg $ vol (20d)57.76M
Market cap2.38B
RS 3m (vs SPY)+35.87%
RS 6m (vs SPY)+28.17%
RS line new highNo
Trend template5/8
Technical rank88.4
1 week+7.91%
1 month+34.15%
3 months+42.92%
6 months+34.71%
1 year+21.94%
YTD+5.63%
P/E-3.33
P/B1.56
P/S1.28
P/FCF-7.73
EPS-7.13
Div yield—
ROE-46.70%
ROA-22.37%
Debt/Eq0.00
Current4.42
EV/EBITDA-2.76
Gross margin-1.56%
Net margin-38.27%
Rev growth4.27%
EPS growth-403.27%
Price target22.88
Target upside1.64%
Analyst ratingHold
Institutional115.23%
Ent. value1.81B
Revenue328.69M
Net income-4.89M
Gross profit—
Free cash flow-307.45M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out105.58M
Employees835
ListedWed, Jun 4, 1997
Free float96.61M
Float %92.2%
Short interest27.05M
Days to cover9.1d
Short volume72.5%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.42 vs $0.34
Last surprise+23.5% beat
Setup gradeC
Conviction57 / 100
Pattern quality—
Tech rank88.4 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance23.11
Support15.09
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 26
    1 scan
  2. Breaking out now
    Aug 27
    1 scan

Congress activity

Disclosed STOCK Act trades in SRPT · 1 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-14
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in SRPT · 7 buys

InsiderSideShares
BEHRENS M KATHLEEN
Director · Common Stock · 2026-06-04
Grant16.88K
Connelly Deirdre P
Director · Common Stock · 2026-06-04
Grant16.88K
Wigzell Hans Lennart Rudolf
Director · Common Stock · 2026-06-04
Grant16.88K
Barry Richard
Director · Common Stock · 2026-06-04
Other—
Nicaise Claude
Director · Common Stock · 2026-06-04
Grant16.88K
Barry Richard
Director · Common Stock · 2026-06-04
Grant16.88K
Mayo Stephen
Director · Common Stock · 2026-06-04
Grant16.88K
BEHRENS M KATHLEEN
Director · Common Stock · 2026-06-04
Other—
Chambers Michael Andrew
Director · Common Stock · 2026-06-04
Other—
Chambers Michael Andrew
Director · Common Stock · 2026-06-04
Grant16.88K

SEC filings

EDGAR filings in SRPT · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.